Targeted Protein Degradation (TPD) has created a paradigm shift and emerged as a front-runner in drugging many &quot;undruggable&quot; targets. As a new modality, it poses unique challenges for lead discovery as well as API development and manufacturing.
We will focus on the latest advances in chemical building blocks for protein degradation, including warheads, linkers, and ligands, and how they can be used to build better degraders. Once a candidate has been identified, selection of the right CDMO can take a phase-appropriate approach to develop with commercial readiness in mind, provide partnered quality and regulatory support, and offer batch scalability as you progress through the clinic.
In this webinar, you will learn about:
<ul>
<li>Targeted Protein Degradation (TPD) technologies</li>
<li>A mechanistic view of this new modality</li>
<li>Chemical advancements for modular and strategic degrader design&nbsp;</li>
<li>How to select the appropriate contract manufacturing partner</li>
</ul>

aem-GridColumn aem-GridColumn--default--9

<h2 class="webinar-subtitle">WEBINAR</h2>

aem-GridColumn aem-GridColumn--default--9 aem-GridColumn--offset--default--0 aem-GridColumn--default--none

aem-GridColumn aem-GridColumn--default--3 aem-GridColumn--offset--default--0 aem-GridColumn--default--none

Webinar explores advances in chemical building blocks for protein degradation, including warheads, linkers, and ligands.

Targeted Protein Degradation Partners

WEBINAR